Empowerment in Type 2 diabetes: A patient-centred approach for lifestyle change

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2025-02-01 DOI:10.1016/j.diabres.2025.111998

Charlotte Björk Ingul , Siri Marte Hollekim-Strand , Mari Mørkeset Sandbakk , Torunn Ingfrid Grønseth , Tone Iren K. Rånes , Lars Tung Dyrendahl , Katarina Eilertsen , Stephan Kristensen , Turid Follestad , Bjarte Bye Løfaldli

{"title":"Empowerment in Type 2 diabetes: A patient-centred approach for lifestyle change","authors":"Charlotte Björk Ingul , Siri Marte Hollekim-Strand , Mari Mørkeset Sandbakk , Torunn Ingfrid Grønseth , Tone Iren K. Rånes , Lars Tung Dyrendahl , Katarina Eilertsen , Stephan Kristensen , Turid Follestad , Bjarte Bye Løfaldli","doi":"10.1016/j.diabres.2025.111998","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To evaluate the effectiveness of personalized lifestyle intervention service for persons with Type 2 diabetes (T2D), implemented in a real-world setting at two Healthy Life Centers (HLC) in Norway.</div></div><div><h3>Methods</h3><div>Persons with T2D were randomized into either an HLC intervention group or a usual care group for 12 weeks. All participants were screened using a questionnaire tool and had one initial patient-centred health conversation at the HLC. In the intervention group, participants chose interventions with support from HLC staff. The usual care group continued independently. Outcome variables were assessed at baseline, 12 weeks, and 24 weeks (if completing two interventions).</div></div><div><h3>Results</h3><div>110 participants were included (mean age 59.9, 59 % T2D duration < 10 years, 36 % females). There was no significant difference in HbA1c change between intervention and usual care groups (mean difference −1.2 mmol/l, 95 % CI: −3.7 to 1.3, p = 0.33). HbA1c was significantly reduced in both groups (mean reduction 3.8 mmol/l (95 % CI: 2.1 to 5.5, p < 0.001) vs. 2.6 mmol/l (95 % CI: 0.7 to 4.4, p = 0.006), respectively).</div></div><div><h3>Conclusions</h3><div>Both the HLC personalized follow-up and usual care groups reduced HbA1c with no significant differences between groups. This suggests that low-threshold municipal healthcare can effectively support lifestyle changes in individuals with T2D.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"220 ","pages":"Article 111998"},"PeriodicalIF":6.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725000129","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

To evaluate the effectiveness of personalized lifestyle intervention service for persons with Type 2 diabetes (T2D), implemented in a real-world setting at two Healthy Life Centers (HLC) in Norway.

Methods

Persons with T2D were randomized into either an HLC intervention group or a usual care group for 12 weeks. All participants were screened using a questionnaire tool and had one initial patient-centred health conversation at the HLC. In the intervention group, participants chose interventions with support from HLC staff. The usual care group continued independently. Outcome variables were assessed at baseline, 12 weeks, and 24 weeks (if completing two interventions).

Results

110 participants were included (mean age 59.9, 59 % T2D duration < 10 years, 36 % females). There was no significant difference in HbA1c change between intervention and usual care groups (mean difference −1.2 mmol/l, 95 % CI: −3.7 to 1.3, p = 0.33). HbA1c was significantly reduced in both groups (mean reduction 3.8 mmol/l (95 % CI: 2.1 to 5.5, p < 0.001) vs. 2.6 mmol/l (95 % CI: 0.7 to 4.4, p = 0.006), respectively).

Conclusions

Both the HLC personalized follow-up and usual care groups reduced HbA1c with no significant differences between groups. This suggests that low-threshold municipal healthcare can effectively support lifestyle changes in individuals with T2D.

查看原文本刊更多论文

2型糖尿病的赋权：以患者为中心的生活方式改变方法

目的：评估个性化生活方式干预服务对2型糖尿病（T2D）患者的有效性，该服务在挪威两家健康生活中心（HLC）的现实环境中实施。方法：将T2D患者随机分为hcc干预组或常规护理组，为期12 周。所有参与者使用问卷工具进行筛选，并在HLC进行一次以患者为中心的初步健康对话。在干预组中，参与者在HLC工作人员的支持下选择干预措施。常规护理组继续独立治疗。在基线、12 周和24 周（如果完成两项干预）评估结果变量。结果：纳入110名参与者（平均年龄59.9岁，59 % T2D持续时间 ）。结论：HLC个性化随访组和常规护理组均降低了HbA1c，组间无显著差异。这表明低门槛的城市医疗保健可以有效地支持t2dm患者生活方式的改变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.